A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)

NCT02905578 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neoplasms
Cancer of Pancreas
Cancer of the Pancreas
Neoplasms, Pancreatic
Pancreas Cancer
Pancreas Neoplasms
Adenocarcinoma

Interventions

DRUG: Gemcitabine
DRUG: nab-paclitaxel
DRUG: Pharmacological ascorbate

Sponsor

Joseph J. Cullen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]